Physician profile
Biren M Patel
NPI 1851336184
$6,679.73
in general payments reported to CMS, 2019-2025
50 companies · $1,133 in 2025
The $1,133 reported for 2025 was more than what a typical Urology provider received nationally (typical 2025 total: $631).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $1,948 · 2020: $571 · 2021: $759 · 2022: $609 · 2023: $828 · 2024: $832 · 2025: $1,133.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $2,766 · Education: $26.38.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $2,766.14 |
| Education | $26.38 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Neotract INC. | $1,243.42 | 2019 | |
| Janssen Biotech, INC. | $567.55 | 2019-2025 | Erleada |
| Myriad Genetic Laboratories, INC. | $531.89 | 2020-2024 | Prolaris |
| Pfizer INC. | $449.29 | 2019-2025 | |
| Boston Scientific Corporation | $401.31 | 2019-2025 | Solyx Sis System, Lithoclast, Lithovue |
| Urogen Pharma, INC. | $317.10 | 2020-2025 | Jelmyto |
| Astellas Pharma US INC | $304.63 | 2019-2025 | Xtandi |
| Blue Earth Diagnostics | $248.02 | 2019-2025 | Posluma |
| Femselect INC. | $232.46 | 2025 | Enplace |
| Teleflex LLC | $201.37 | 2023-2025 | Urolift, Barrigel |
| Sumitomo Pharma America, INC. | $142.25 | 2024-2025 | Orgovyx, Gemtesa |
| Coloplast Corp | $131.91 | 2019-2024 | Saffron |
| Myovant Sciences INC. | $129.34 | 2021-2022 | |
| Bayer Healthcare Pharmaceuticals INC. | $113.26 | 2019-2025 | |
| Antares Pharma, INC. | $102.70 | 2019-2025 | Xyosted |
Show all 50 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Astrazeneca Pharmaceuticals LP | $94.89 | 2020-2025 | Lynparza |
| Procept Biorobotics Corporation | $94.59 | 2024-2025 | Aquabeam System |
| Axonics, INC. | $92.24 | 2021-2024 | Axonics |
| Medtronic, INC. | $91.00 | 2021-2022 | |
| Novartis Pharmaceuticals Corporation | $88.38 | 2024-2025 | |
| Abbvie INC. | $76.48 | 2021-2024 | |
| Endo USA, INC. | $76.39 | 2024-2025 | Xiaflex, Aveed |
| Karl Storz Endoscopy-America | $75.78 | 2021 | |
| 180 Medical, INC. | $74.00 | 2024-2025 | Gentlecath Glide |
| Ferring Pharmaceuticals INC. | $61.58 | 2024-2025 | Adstiladrin |
| Rochester Medical Corporation | $57.94 | 2021-2022 | |
| Tolmar Pharmaceuticals, INC. | $57.32 | 2020-2022 | |
| Sun Pharmaceutical Industries INC. | $56.99 | 2019-2022 | |
| Laborie Medical Technologies Corp. | $52.25 | 2024 | Optilume Bph Drug Coated Balloon Catheter, Endosheath Technology |
| Endo Pharmaceuticals INC. | $50.04 | 2020-2021 | |
| Innovation Technologies INC | $40.06 | 2023-2024 | Irrisept |
| Accord Healthcare, INC. | $34.42 | 2022-2024 | |
| Progenics Pharmaceuticals, INC. | $34.18 | 2022-2023 | Pylarify |
| Baxter Healthcare | $31.88 | 2025 | Floseal |
| Caldera Medical, INC | $31.69 | 2021 | |
| Novo Nordisk INC | $31.36 | 2025 | Rivfloza |
| Olympus America INC. | $27.89 | 2021-2025 | Itind System |
| Smith+Nephew, INC. | $24.20 | 2020-2024 | Stravix Pl |
| Immunitybio, INC. | $22.20 | 2024 | |
| Merck Sharp & Dohme LLC | $21.53 | 2021 | |
| Calyxo, INC. | $21.43 | 2025 | Cvac Aspiration System |
| Convatec INC. | $19.91 | 2023 | |
| Foundation Medicine, INC. | $19.48 | 2020 | |
| C. R. Bard, INC. & Subsidiaries | $16.76 | 2025 | Bard Urinary Drainage Bag |
| Agiliti Surgical, INC. | $16.47 | 2025 | Sonablate Hifu |
| Genzyme Corporation | $15.90 | 2020 | |
| Tolmar, INC. | $14.70 | 2024 | |
| Therapeuticsmd, INC. | $14.69 | 2019 | |
| Dentsply Ih INC. | $13.81 | 2019 | |
| Zyla Life Sciences, INC. | $10.80 | 2019 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Biren Patel listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.